Wilmer Cutler Pickering Hale and Dorr advised Apellis Pharmaceuticals on the deal. Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) and Beam Therapeutics Inc. (Nasdaq: BEAM), announced that they...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised Cue Health Inc. on the deal. Cue Health Inc., a health technology company, announced the closing of its $235...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised UNTUCKit on the deal. Second Avenue Capital Partners, LLC (“SACP”) announced it has closed on a $30,000,000 senior secured...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised Amplitude Healthcare Corporation on the deal while Paul Hastings represented Jasper Therapeutics. Amplitude Healthcare Corporation (Nasdaq: AMHC), a special...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr LLP advised Zaius on the deal. Optimizely (formerly Episerver), a leading provider of digital experience platform solutions, announced it has...
You must be a Standard 1 Year member to access this content.
